New Jersey 2026-2027 Regular Session

New Jersey Assembly Bill A3655

Introduced
1/13/26  

Caption

Extends "Epinephrine Access and Emergency Treatment Act" to include administration of epinephrine auto-injector devices by individuals in possession of devices pursuant to personal prescriptions.

Impact

The implications of A3655 extend directly to state health and safety regulations, particularly surrounding emergency medical interventions. By making it explicit that individuals with a prescription can administer epinephrine without fear of legal repercussions, the bill encourages swift action during life-threatening allergic reactions. This modification in law is anticipated to enhance public health response and potentially save lives by mitigating hesitation about administering a potentially life-saving medication in emergencies.

Summary

Assembly Bill A3655 seeks to amend the existing 'Epinephrine Access and Emergency Treatment Act' by allowing individuals who possess an epinephrine auto-injector device under a valid prescription to administer it to others in emergency situations. The bill aims to increase accessibility to epinephrine for those experiencing severe allergic reactions (anaphylaxis) and promotes proactive measures during medical emergencies. As per the proposed changes, these individuals would not face civil liability provided their actions are done in good faith and without any financial gain.

Contention

While the bill is likely to gain substantial support given its focus on public health, there are potential concerns regarding the qualifications and readiness of individuals to administer medical interventions. Critics may argue that while increasing access is essential, it raises questions about ensuring that those administering epinephrine have adequate training and understanding of when and how to use the device correctly. Hence, balancing expanded access to epinephrine with the need for proper training and guidance could emerge as an area of contention during discussions.

Companion Bills

NJ A3067

Carry Over Extends "Epinephrine Access and Emergency Treatment Act" to include administration of epinephrine auto-injector devices by individuals in possession of devices pursuant to personal prescriptions.

Similar Bills

TX HB2283

Relating to the use of an epinephrine delivery device by certain entities.

TX SB1619

Relating to the use of an epinephrine delivery system by certain entities.

TX SB1374

Relating to the administration of epinephrine medication by public and private schools.

TX HB2801

Relating to the definition of an epinephrine delivery device and the use of those devices in public and private schools.

MS SB2197

Epinephrine auto-injectors; allow certain entities to stock and provide or administer during anaphylactic emergencies.

IA HF2055

A bill for an act relating to epinephrine delivery systems in schools, food establishments, carnivals, recreational camps, youth sports facilities, and sports arenas.(See HF 2203.)

IA HF2203

A bill for an act relating to epinephrine delivery systems in schools, food establishments, carnivals, recreational camps, youth sports facilities, and sports arenas.(Formerly HF 2055.)

CA SB568

Pupil health: epinephrine delivery systems: schoolsites and childcare programs.